Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8344654rdf:typepubmed:Citationlld:pubmed
pubmed-article:8344654lifeskim:mentionsumls-concept:C1551338lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C0206633lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C0751674lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C0018552lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:8344654lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:8344654pubmed:issue5lld:pubmed
pubmed-article:8344654pubmed:dateCreated1993-9-3lld:pubmed
pubmed-article:8344654pubmed:abstractTextAngiomyolipoma is a hamartomatous condition which can occur as a component of the tuberous sclerosis complex. Lymphangiomyomatosis, another hamartomatous lesion occurring predominantly in the lungs, has long been suspected to be related to angiomyolipoma and tuberous sclerosis because of occasional clinical associations. We undertook this study to provide further support for the close relationship between these two entities. Five cases of lymphangiomyomatosis and 20 case of angiomyolipoma were retrieved for histological review and immunohistochemical studies. The antibodies used were anti-muscle specific actin (HHF-35), anti-desmin (D33) and anti-melanoma (HMB-45). Lesions featuring smooth muscle proliferation were used as controls. The proliferated smooth muscle cells in both lymphangiomyomatosis and angiomyolipoma were much plumper and paler or even clear, when compared with the deeply eosinophilic cytoplasm of the normal spindly smooth muscle cells and those of leiomyomas. Their nuclei were round to oval and pale rather than elongated and dark. Cells with bizarre nuclei were commoner in angiomyolipoma (18/20 cases) than lymphangiomyomatosis (1/5). In 12 cases of angiomyolipoma there were foci indistinguishable from lymphangiomyomatosis, i.e. plump spindle cells arranged in short fascicles around ramifying endothelium-lined spaces. All five cases of lymphangiomyomatosis stained for muscle-specific actin, desmin and HMB-45. For angiomyolipomas, the positivity rates for these markers were: 20/20, 17/20 and 18/20, respectively, including one case that was negative for both desmin and HMB-45. The various smooth muscle proliferations and tumours selected as controls were uniformly HMB-45 negative. The distinctive cytological features, morphological overlap and immunophenotypic profile all support a close relationship between lymphangiomyomatosis and angiomyolipoma, which probably represent different morphological manifestations of hamartomatous proliferation of a peculiar form of HMB-45-positive smooth muscle.lld:pubmed
pubmed-article:8344654pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8344654pubmed:languageenglld:pubmed
pubmed-article:8344654pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8344654pubmed:citationSubsetIMlld:pubmed
pubmed-article:8344654pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8344654pubmed:statusMEDLINElld:pubmed
pubmed-article:8344654pubmed:monthMaylld:pubmed
pubmed-article:8344654pubmed:issn0309-0167lld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:ChaoJ JJJlld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:FletcherC DCDlld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:BEUK EKElld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:TsangW YWYlld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:LeebC SCSlld:pubmed
pubmed-article:8344654pubmed:authorpubmed-author:TangM CMClld:pubmed
pubmed-article:8344654pubmed:issnTypePrintlld:pubmed
pubmed-article:8344654pubmed:volume22lld:pubmed
pubmed-article:8344654pubmed:ownerNLMlld:pubmed
pubmed-article:8344654pubmed:authorsCompleteYlld:pubmed
pubmed-article:8344654pubmed:pagination445-55lld:pubmed
pubmed-article:8344654pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:meshHeadingpubmed-meshheading:8344654-...lld:pubmed
pubmed-article:8344654pubmed:year1993lld:pubmed
pubmed-article:8344654pubmed:articleTitleLymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle.lld:pubmed
pubmed-article:8344654pubmed:affiliationInstitute of Pathology, Queen Elizabeth Hospital, London, UK.lld:pubmed
pubmed-article:8344654pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8344654lld:pubmed